Product Description
CD22 Antibody [hL22 (Epratuzumab) ], Human IgG1 | 24-491 | ProSci
Product Type: Primary Antibodies, Drug Analogues
Research Area: Cancer, Immunology, Other
Host Species: N/A
Species Reactivity: Human, Rhesus Monkey, Cynomolgus Monkey
Homology: N/A
Immunogen: This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5–10% of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity (Traczewski, 2010) .
Tested Application: Bl, IP, Flow
Predicted MW: N/A
Purification: N/A
Clonality: N/A
Clone: hL22 (Epratuzumab)
Isotype: IgG1 kappa
Conjugate: Unconjugated
Physical State: N/A
Buffer: PBS with 0.02% Proclin 300.
Concentration: batch dependent
Storage: Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C.
Additional Names: Leu14, B-cell receptor CD22, B-lymphocyte cell adhesion molecule, BL-CAM, Sialic acid-binding Ig-like lectin 2, Siglec-2, T-cell surface antigen Leu-14
Background: N/A
Shipping Condition: Blue Ice
Source: N/A
Species: Human
Peptide Location: N/A
By Source: N/A
By Species: N/A
Recombinant Protein Sequence: N/A
Badges: N/A